These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25676612)

  • 1. Rational use of medicines in older adults: Can we do better during clinical development?
    Saeed MA; Vlasakakis G; Della Pasqua O
    Clin Pharmacol Ther; 2015 May; 97(5):440-3. PubMed ID: 25676612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling and simulation in pediatric drug therapy: Application of pharmacometrics to define the right dose for children.
    Vinks AA; Emoto C; Fukuda T
    Clin Pharmacol Ther; 2015 Sep; 98(3):298-308. PubMed ID: 26073179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development.
    Wang J; Avant D; Green D; Seo S; Fisher J; Mulberg AE; McCune SK; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):328-35. PubMed ID: 25975723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of biomarkers in human pharmacology (Phase I) studies.
    Cohen AF; Burggraaf J; van Gerven JM; Moerland M; Groeneveld GJ
    Annu Rev Pharmacol Toxicol; 2015; 55():55-74. PubMed ID: 25292425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal drug therapy: The first frontier of therapeutics for children.
    Allegaert K; van den Anker J
    Clin Pharmacol Ther; 2015 Sep; 98(3):288-97. PubMed ID: 26095519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failed Pediatric Drug Development Trials.
    Momper JD; Mulugeta Y; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):245-51. PubMed ID: 25963725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring as a component of personalized medicine: applications in pediatric drug development.
    Momper JD; Wagner JA
    Clin Pharmacol Ther; 2014 Feb; 95(2):138-40. PubMed ID: 24253660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology for the geriatric surgical patient.
    Then J; Tisherman SA
    Surg Clin North Am; 2015 Feb; 95(1):139-47. PubMed ID: 25459548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to the theme "Precision medicine and prediction in pharmacology".
    Insel PA; Amara SG; Blaschke TF
    Annu Rev Pharmacol Toxicol; 2015; 55():11-4. PubMed ID: 25562643
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of the relationship between a starting dose in first-in-human studies and no observed adverse effect level in nonclinical studies.
    Sato A; Narukawa M
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):770-6. PubMed ID: 25034619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting the proper pediatric dose: It is more than size that matters.
    Kearns GL
    Clin Pharmacol Ther; 2015 Sep; 98(3):238-40. PubMed ID: 26073060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study.
    Tosato M; Landi F; Martone AM; Cherubini A; Corsonello A; Volpato S; Bernabei R; Onder G;
    Age Ageing; 2014 Nov; 43(6):767-73. PubMed ID: 24637848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric microdose and microtracer studies using 14C in Europe.
    Turner MA; Mooij MG; Vaes WH; Windhorst AD; Hendrikse NH; Knibbe CA; Kõrgvee LT; Maruszak W; Grynkiewicz G; Garner RC; Tibboel D; Park BK; de Wildt SN
    Clin Pharmacol Ther; 2015 Sep; 98(3):234-7. PubMed ID: 26095095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of inflammatory bowel disease in the elderly: balancing safety and efficacy.
    Ha CY
    Clin Geriatr Med; 2014 Feb; 30(1):67-78. PubMed ID: 24267603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital readmission for adverse drug reactions.
    Prescrire Int; 2015 Feb; 24(157):46. PubMed ID: 25802920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model-based approach to dose selection in early pediatric development.
    Cella M; Gorter de Vries F; Burger D; Danhof M; Della Pasqua O
    Clin Pharmacol Ther; 2010 Mar; 87(3):294-302. PubMed ID: 20107435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Before crushing a tablet or opening a capsule...
    Prescrire Int; 2014 Sep; 23(152):211. PubMed ID: 25325121
    [No Abstract]   [Full Text] [Related]  

  • 18. The credibility of the FDA.
    Blankfield RP
    Eur J Prev Cardiol; 2013 Dec; 20(6):992-4. PubMed ID: 23867140
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescribing errors in adult congenital heart disease patients admitted to a pediatric cardiovascular intensive care unit.
    Echeta G; Moffett BS; Checchia P; Benton MK; Klouda L; Rodriguez FH; Franklin W
    Congenit Heart Dis; 2014; 9(2):126-30. PubMed ID: 23773504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a need for a universal benefit-risk assessment framework for medicines? Regulatory and industry perspectives.
    Leong J; McAuslane N; Walker S; Salek S
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):1004-12. PubMed ID: 23740622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.